Tag Archives: Madison Vaccines

MVI logo

MVI Provides Trial Update

In its clinical trial to treat prostate cancer, Madison Vaccines Incorporated (MVI) announced today it has begun dosing 20 patients. According to a release, MVI is exploring the use of its gene…

MVI logo

MVI Expands Clinical Trial

Madison Vaccines Incorporated’s clinical trial for metastatic prostate cancer is expanding to the University of Washington, its third site, the company announced recently. According to a release, MVI-118 is being explored for…

MVI logo

MVI Vaccine Shows ‘Promise’ vs. Cancer

Madison Vaccines Incorporated (MVI) announced today it will present data at the Society for Immunotherapy of Cancer’s Annual Meeting on Nov. 11 in National Harbor, Md., that has “promise” to stimulate an immune…

MVI logo

Madison Vaccines Completes Series A

Madison Vaccines Incorporated (MVI) announced this week it raised $8 million in a Series A financing round led by Venture Investors, LLC. The Madison-based biopharmaceutical company seeks to advance research and clinical testing…